AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32702697 — intervention group
Group type: COMPARATOR
Intervention: Lower calyx entry (group 2)
Number of subjects: 70
Study 35820832 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibromyalgia Self-management Programme (FSMP), consisting of one 2.5-hour weekly session over six weeks.
Number of subjects: 74
Study 35820832 — intervention group
Group type: COMPARATOR
Intervention: Control arm (details not specified in the abstract).
Number of subjects: 74
Study 35820832 — intervention group
Group type: EXPERIMENTAL
Intervention: FSMP (intervention)
Number of subjects: 74
Study 32525416 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic saline
Number of subjects: 200
Study 32525416 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 200
Study 32525416 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylometazoline
Number of subjects: 200
Study 32525416 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotonic saline
Number of subjects: 200
Study 34172722 — intervention group
Group type: EXPERIMENTAL
Intervention: PD-L1 blockade
Number of subjects: 366
Study 33222610 — intervention group
Group type: EXPERIMENTAL
Intervention: 50, 100 or 150 L3 Necator americanus larvae
Number of subjects: 0
Study 33222610 — intervention group
Group type: EXPERIMENTAL
Intervention: GI symptoms
Number of subjects: 0
Study 33222610 — intervention group
Group type: EXPERIMENTAL
Intervention: Barnesiella and other taxa
Number of subjects: 0
Study 34941114 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized enriched heparin (2.5 mg/mL 0.9% saline)
Number of subjects: 50
Study 34941114 — intervention group
Group type: COMPARATOR
Intervention: Placebo (nebulized 0.9% saline)
Number of subjects: 50
Study 34493643 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal intervention for 1 week
Number of subjects: 46
Study 34493643 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 46
Study 32896292 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (500 mg via oral, nasogastric, or intravenous administration once daily for 10 days) plus standard of care (hydroxychloroquine 400 mg twice daily for 10 days)
Number of subjects: 397
Study 32896292 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (hydroxychloroquine 400 mg twice daily for 10 days) without macrolides
Number of subjects: 397
Study 35817323 — intervention group
Group type: COMPARATOR
Intervention: 40 Gy/15 fractions/3 weeks (standard treatment)
Number of subjects: 271
Study 35817323 — intervention group
Group type: EXPERIMENTAL
Intervention: 26 Gy/5 fractions/1 week (novel treatment)
Number of subjects: 271
Study 35817323 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 Gy/5 fractions/1 week (to the tumour bed, SIB)
Number of subjects: 271
Study 35817323 — intervention group
Group type: COMPARATOR
Intervention: 12 Gy/4 fractions/4 days (sequential boost)
Number of subjects: 271
Study 34606595 — intervention group
Group type: EXPERIMENTAL
Intervention: TAK-003
Number of subjects: 20099
Study 34606595 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20099
Study 32309986 — intervention group
Group type: EXPERIMENTAL
Intervention: Holistic Yoga Program (HYP)
Number of subjects: 209
Study 32309986 — intervention group
Group type: COMPARATOR
Intervention: Wellness Lifestyle Program (WLP)
Number of subjects: 209
Study 36231152 — intervention group
Group type: EXPERIMENTAL
Intervention: Ashwagandha (ASH) 400 mg
Number of subjects: 13
Study 36231152 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 13
Study 32109176 — intervention group
Group type: EXPERIMENTAL
Intervention: Implicit problem‐solving (identification condition)
Number of subjects: 45
Study 32109176 — intervention group
Group type: EXPERIMENTAL
Intervention: Explicit problem‐solving (reflection condition)
Number of subjects: 45
Study 32109176 — intervention group
Group type: COMPARATOR
Intervention: No practice (control condition)
Number of subjects: 45
Study 35156040 — intervention group
Group type: EXPERIMENTAL
Intervention: Responsive bassinet used until 6 months postpartum
Number of subjects: 114
Study 35156040 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist‐assisted cognitive behavioral therapy for insomnia
Number of subjects: 114
Study 35156040 — intervention group
Group type: COMPARATOR
Intervention: Sleep hygiene booklet
Number of subjects: 114
Study 35156040 — intervention group
Group type: EXPERIMENTAL
Intervention: Responsive bassinet
Number of subjects: 114
Study 33591621 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 273
Study 33591621 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 273
Study 35525992 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise rehabilitation with behavioural and motivational support, delivered remotely online, consisting of individual assessment, 12-week, twice-weekly supervised exercise training, and guided lifestyle physical activity.
Number of subjects: 62
Study 35525992 — intervention group
Group type: COMPARATOR
Intervention: Best-practice usual care, delivered remotely online, consisting of a single 30-min, one-to-one practitioner appointment, and general advice on safe and effective physical activity.
Number of subjects: 62
Study 33431279 — intervention group
Group type: EXPERIMENTAL
Intervention: Chiropractic care (10 sessions over 14 weeks) plus enhanced usual care
Number of subjects: 29
Study 33431279 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care alone
Number of subjects: 29
Study 33970363 — intervention group
Group type: EXPERIMENTAL
Intervention: Online training program
Number of subjects: 32
Study 32720779 — intervention group
Group type: EXPERIMENTAL
Intervention: LT (local training)
Number of subjects: 108
Study 32720779 — intervention group
Group type: EXPERIMENTAL
Intervention: GT (global training)
Number of subjects: 108
Study 32720779 — intervention group
Group type: COMPARATOR
Intervention: CG (control group)
Number of subjects: 108
Study 35897114 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate revascularisation plus optimised medical therapy (OMT)
Number of subjects: 320
Study 35897114 — intervention group
Group type: COMPARATOR
Intervention: Optimised medical therapy (OMT) alone
Number of subjects: 320
Study 34347723 — intervention group
Group type: EXPERIMENTAL
Intervention: EUS-FNA with ROSE
Number of subjects: 65
Study 34347723 — intervention group
Group type: COMPARATOR
Intervention: EUS-FNA without ROSE (non-ROSE)
Number of subjects: 65
Study 32314631 — intervention group
Group type: EXPERIMENTAL
Intervention: Men reporting erectile dysfunction (ED)
Number of subjects: 48910
Study 32314631 — intervention group
Group type: EXPERIMENTAL
Intervention: Men who contacted a GP regarding ED
Number of subjects: 48910
Study 32314631 — intervention group
Group type: EXPERIMENTAL
Intervention: Age, smoking status, alcohol consumption, BMI, self-rated physical fitness
Number of subjects: 48910
Study 32314631 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 48910
Study 32314631 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical fitness
Number of subjects: 48910
Study 34762528 — intervention group
Group type: EXPERIMENTAL
Intervention: Bosentan (125 mg twice a day for 3 days)
Number of subjects: 40
Study 34762528 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 34194732 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5% chlorhexidine solution and 0.9% NaCl
Number of subjects: 40
Study 34194732 — intervention group
Group type: COMPARATOR
Intervention: 0.9% NaCl
Number of subjects: 40
Study 36332661 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextromethorphan (60mg loading dose and two subsequent 30mg doses at 2 and 5 hours after misoprostol)
Number of subjects: 156
Study 36332661 — intervention group
Group type: COMPARATOR
Intervention: Placebo (combined with usual-care non-steroidal anti-inflammatory medications +/− opioids)
Number of subjects: 156
Study 32805205 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 μg lubiprostone
Number of subjects: 150
Study 32805205 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 μg lubiprostone
Number of subjects: 150
Study 32805205 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 36180139 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal approach (MET, cervical and scapulothoracic stabilization exercises, postural correction training with ergonomic advice)
Number of subjects: 40
Study 36180139 — intervention group
Group type: COMPARATOR
Intervention: MET only (control group)
Number of subjects: 40
Study 33295809 — intervention group
Group type: COMPARATOR
Intervention: Lorazepam (0.05 mg/kg bolus followed by 4-h normal saline infusion)
Number of subjects: 19
Study 33295809 — intervention group
Group type: EXPERIMENTAL
Intervention: Physostigmine (0.02 mg/kg bolus followed by 4-h infusion at 0.02 mg/kg/h)
Number of subjects: 19
Study 33073935 — intervention group
Group type: COMPARATOR
Intervention: Patients with PsA only (Group I)
Number of subjects: 60
Study 33073935 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with FM-PsA (Group II)
Number of subjects: 60
Study 36361061 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaping prevention messages (n = 295)
Number of subjects: 569
Study 36361061 — intervention group
Group type: COMPARATOR
Intervention: Sun safety messages (n = 274)
Number of subjects: 569
Study 32726499 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine GITS 30 mg administered in the morning (N-M)
Number of subjects: 120
Study 32726499 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine GITS 30 mg administered at night (N-N)
Number of subjects: 120
Study 32726499 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine besylate 5 mg administered in the morning (A-M)
Number of subjects: 120
Study 32726499 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine besylate 5 mg administered at night (A-N)
Number of subjects: 120
Study 32726499 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine GITS and Amlodipine besylate (both drugs)
Number of subjects: 120
Study 34507102 — intervention group
Group type: EXPERIMENTAL
Intervention: CDP-choline (2 g/day for 8 weeks)
Number of subjects: 44
Study 34507102 — intervention group
Group type: COMPARATOR
Intervention: Placebo (for 8 weeks)
Number of subjects: 44
Study 36286885 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietressa (6 tablets per day for 24 weeks)
Number of subjects: 493
Study 36286885 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Dietressa group
Number of subjects: 493
Study 36286885 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietressa-1 group
Number of subjects: 493
Study 36286885 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietressa-2 group
Number of subjects: 493
Study 36286885 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietressa
Number of subjects: 493
Study 33301386 — intervention group
Group type: EXPERIMENTAL
Intervention: Xbox 360 Kinect activity (30 minutes, three times per week for 6 weeks)
Number of subjects: 36
Study 33301386 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal daily routine)
Number of subjects: 36
Study 35245879 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep Brain Stimulation (DBS) in Subthalamic nucleus (STN)
Number of subjects: 21
Study 35245879 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep Brain Stimulation (DBS) in internal pallidum (GPi)
Number of subjects: 21
Study 35245879 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep Brain Stimulation (DBS) in STN
Number of subjects: 21
Study 35245879 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep Brain Stimulation (DBS) in both STN and GPi
Number of subjects: 21
Study 35245879 — intervention group
Group type: COMPARATOR
Intervention: Deep Brain Stimulation (DBS) in STN and GPi
Number of subjects: 21
Study 33428746 — intervention group
Group type: EXPERIMENTAL
Intervention: CrashCourse (CC)
Number of subjects: 118
Study 33428746 — intervention group
Group type: EXPERIMENTAL
Intervention: Centers for Disease Control and Prevention (CDC) video education materials (CDC‐Vi)
Number of subjects: 118
Study 33428746 — intervention group
Group type: COMPARATOR
Intervention: CDC written education materials (CDC‐Wr)
Number of subjects: 118
Study 33428746 — intervention group
Group type: EXPERIMENTAL
Intervention: All education formats
Number of subjects: 118
Study 33428746 — intervention group
Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 118
Study 36470113 — intervention group
Group type: EXPERIMENTAL
Intervention: Water sweetened with saccharine, sucralose, or aspartame + acesulfame-K (Asp+Ace-K)
Number of subjects: 42
Study 36470113 — intervention group
Group type: COMPARATOR
Intervention: Plain water (control group)
Number of subjects: 42
Study 36470113 — intervention group
Group type: EXPERIMENTAL
Intervention: Water sweetened with LNCS
Number of subjects: 42
Study 35212274 — intervention group
Group type: EXPERIMENTAL
Intervention: GSMs-TACE plus synchronous antigen-presenting dendritic cell (DC) sequential reinfusion
Number of subjects: 0
Study 35212274 — intervention group
Group type: COMPARATOR
Intervention: GSMs-TACE (control group)
Number of subjects: 0
Study 32043439 — intervention group
Group type: EXPERIMENTAL
Intervention: Formal education
Number of subjects: 403
Study 32043439 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous exposure to health education
Number of subjects: 403
Study 32043439 — intervention group
Group type: EXPERIMENTAL
Intervention: Interest in vector control tools
Number of subjects: 403
Study 32043439 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge scores
Number of subjects: 403
Study 32043439 — intervention group
Group type: EXPERIMENTAL
Intervention: Protective measures usage
Number of subjects: 403
Study 36151584 — intervention group
Group type: EXPERIMENTAL
Intervention: Perinatal Emotional Skills Groups (ESGs) + Treatment as Usual (TAU)
Number of subjects: 0
Study 36151584 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 0
Study 34962562 — intervention group
Group type: EXPERIMENTAL
Intervention: Inquiry-Based Stress Reduction (IBSR) program for 12 weeks
Number of subjects: 100
Study 34962562 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 100
Study 34802026 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical tranexamic acid (tTXA) 1g (20mL) soaked in absorbable gelatin sponge
Number of subjects: 65
Study 34802026 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline 20mL)
Number of subjects: 65
Study 34802026 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical tranexamic acid (tTXA)
Number of subjects: 65
Study 34802026 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 65
Study 33191360 — intervention group
Group type: EXPERIMENTAL
Intervention: J-Valve
Number of subjects: 163
Study 33191360 — intervention group
Group type: EXPERIMENTAL
Intervention: Venus‐A
Number of subjects: 163
Study 33191360 — intervention group
Group type: EXPERIMENTAL
Intervention: SAPIEN
Number of subjects: 163
Study 33191360 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 163
Study 35948761 — intervention group
Group type: EXPERIMENTAL
Intervention: SnF2 without‐iontophoresis
Number of subjects: 26
Study 35948761 — intervention group
Group type: EXPERIMENTAL
Intervention: SnF2 with‐iontophoresis
Number of subjects: 26
Study 35948761 — intervention group
Group type: COMPARATOR
Intervention: No SnF2 treatment
Number of subjects: 26
Study 35403584 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol-based hand-rub disinfection
Number of subjects: 0
Study 35403584 — intervention group
Group type: COMPARATOR
Intervention: Prior cleaning of stethoscopes
Number of subjects: 0
Study 33144087 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive test for Helicobacter pylori (Hp) infection
Number of subjects: 310
Study 33144087 — intervention group
Group type: EXPERIMENTAL
Intervention: Hp screening as part of clinical routine during AMI hospitalization
Number of subjects: 310
Study 34267064 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial Extracorporeal Shockwave Therapy (rESWT)
Number of subjects: 102
Study 34267064 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous Blood Injection (ABI)
Number of subjects: 102
Study 33932485 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate coronary angiography
Number of subjects: 552
Study 33932485 — intervention group
Group type: COMPARATOR
Intervention: Delayed coronary angiography
Number of subjects: 552
Study 32597889 — intervention group
Group type: EXPERIMENTAL
Intervention: Detravenol
Number of subjects: 106
Study 32597889 — intervention group
Group type: COMPARATOR
Intervention: Detralex®
Number of subjects: 106
Study 35275078 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based intervention
Number of subjects: 204
Study 35275078 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based intervention
Number of subjects: 204
Study 35275078 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine care)
Number of subjects: 204
Study 36775506 — intervention group
Group type: EXPERIMENTAL
Intervention: Myofascial Release (MFR) techniques
Number of subjects: 42
Study 33410387 — intervention group
Group type: EXPERIMENTAL
Intervention: Working Memory Training (WMT), 5-week adaptive program, n = 37
Number of subjects: 75
Study 33410387 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group, n = 38
Number of subjects: 75
Study 33410387 — intervention group
Group type: EXPERIMENTAL
Intervention: Working Memory Training (WMT)
Number of subjects: 75
Study 32342889 — intervention group
Group type: EXPERIMENTAL
Intervention: Warp knitted spacer fabrics on car seat shell
Number of subjects: 16
Study 32342889 — intervention group
Group type: COMPARATOR
Intervention: Standard seat
Number of subjects: 16
Study 32342889 — intervention group
Group type: EXPERIMENTAL
Intervention: Anthropodynamic dummy test
Number of subjects: 16
Study 35363455 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginal electrical stimulation (IVES) two times a week for 10 weeks
Number of subjects: 52
Study 35363455 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginal electrical stimulation (IVES) five times a week for 4 weeks
Number of subjects: 52
Study 33507949 — intervention group
Group type: EXPERIMENTAL
Intervention: NAT-C guided consultation (Arm I)
Number of subjects: 47
Study 33507949 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Arm II)
Number of subjects: 47
Study 33507949 — intervention group
Group type: EXPERIMENTAL
Intervention: NAT-C intervention
Number of subjects: 47
Study 34950442 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined spinal-epidural anesthesia
Number of subjects: 115
Study 34950442 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia with tracheal intubation
Number of subjects: 115
Study 32215767 — intervention group
Group type: EXPERIMENTAL
Intervention: Debridement and laser treatment
Number of subjects: 27
Study 32215767 — intervention group
Group type: COMPARATOR
Intervention: Debridement alone (Control)
Number of subjects: 27
Study 36239523 — intervention group
Group type: EXPERIMENTAL
Intervention: New birthing room designed with more person‐centered considerations (n = 204)
Number of subjects: 406
Study 36239523 — intervention group
Group type: COMPARATOR
Intervention: Regular birthing room (n = 202)
Number of subjects: 406
Study 33753147 — intervention group
Group type: EXPERIMENTAL
Intervention: Baicalein tablets (200 mg, 400 mg, 600 mg, or 800 mg)
Number of subjects: 80
Study 33753147 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 33753147 — intervention group
Group type: EXPERIMENTAL
Intervention: Baicalein tablets (200 mg)
Number of subjects: 80
Study 33753147 — intervention group
Group type: EXPERIMENTAL
Intervention: Baicalein tablets (400 mg)
Number of subjects: 80
Study 33753147 — intervention group
Group type: EXPERIMENTAL
Intervention: Baicalein tablets (600 mg)
Number of subjects: 80
Study 33753147 — intervention group
Group type: EXPERIMENTAL
Intervention: Baicalein tablets (800 mg)
Number of subjects: 80
Study 32199520 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal health monitoring (PHM) device for 12 weeks
Number of subjects: 24
Study 32199520 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal health monitoring (PHM) device
Number of subjects: 24
Study 36104159 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple notes with continuous access
Number of subjects: 53
Study 36104159 — intervention group
Group type: COMPARATOR
Intervention: Complex notes with continuous access
Number of subjects: 53
Study 36104159 — intervention group
Group type: COMPARATOR
Intervention: Simple notes with initial access
Number of subjects: 53
Study 36104159 — intervention group
Group type: COMPARATOR
Intervention: Complex notes with initial access
Number of subjects: 53
Study 34174392 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic walking intervention
Number of subjects: 180
Study 34174392 — intervention group
Group type: EXPERIMENTAL
Intervention: Social dance intervention
Number of subjects: 180
Study 34174392 — intervention group
Group type: COMPARATOR
Intervention: Active control
Number of subjects: 180
Study 34794898 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Menghini-type needle (20-gauge antegrade bevel)
Number of subjects: 52
Study 34794898 — intervention group
Group type: COMPARATOR
Intervention: Original 22-gauge reverse bevel needle
Number of subjects: 52
Study 34794898 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 52
Study 33789011 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg upadacitinib
Number of subjects: 1704
Study 33789011 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg upadacitinib
Number of subjects: 1704
Study 33789011 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1704
Study 33789011 — intervention group
Group type: COMPARATOR
Intervention: Adalimumab
Number of subjects: 1704
Study 33789011 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg upadacitinib vs. Adalimumab
Number of subjects: 1704
Study 33789011 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg upadacitinib vs. Adalimumab
Number of subjects: 1704
Study 33789011 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 1704
Study 36131324 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine 1000 mg/day
Number of subjects: 76
Study 36131324 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 32680441 — intervention group
Group type: EXPERIMENTAL
Intervention: SidekickHealth smartphone application
Number of subjects: 37